P2X7受体,在阿尔茨海默氏病中的多面受体
Kaitryn E Ronning1, Paul-Alexandre Déchelle-Marquet1, Yueshen Che1
1INSERM, CNRS, Institut de la Vision, Sorbonne University, F-75012 Paris, France.
International journal of molecular sciences
|July 29, 2023
概括
阿尔茨海默病涉及通过P2X7受体作用的细胞外ATP,导致神经炎症和病理. P2X7基因变异也影响阿尔茨海默氏症的风险,突出其核心作用.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 阿尔茨海默病 (AD) 是一种神经退行性疾病,表现为记忆丧失,粉样质斑块和神经纤维状结.
- 在AD中,神经元损伤释放细胞外ATP,信号危险并激活P2X7受体.
- 在AD大脑中,P2X7受体被上调,与疾病进展有关.
研究的目的:
- 审查P2X7受体在阿尔茨海默氏症病原发生中的作用.
- 探索P2X7依赖的途径,有助于AD发展.
主要方法:
- 对阿尔茨海默病中P2X7受体功能研究的文献综述.
- 分析P2X7多态性及其与AD风险的关联.
- 检查P2X7与β-粉样蛋白,tau病理和神经炎症的相互作用.
主要成果:
- 细胞外ATP的P2X7受体激活与AD病理有关.
- P2X7通过NLRP3炎症酶影响粉样质斑块,团和神经炎症.
- 在P2RX7基因的遗传变异影响AD易感性.
结论:
- P2X7受体是阿尔茨海默病的关键调解者,影响病理特征和炎症反应.
- 准P2X7通路为AD提供了潜在的治疗策略.
相关概念视频
Alzheimer's Disease: Overview
522
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
522
Alzheimer's Disease: Treatment
218
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
218
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Ligand-gated Ion Channels
12.5K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.5K
Enzyme-linked Receptors
78.7K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.7K


